Patients with hidradenitis suppurativa (HS) who applied ruxolitinib cream experienced a greater reduction in the abscess and inflammatory nodule count compared to those who used a vehicle cream, according to a phase 2 trial.
Patients with hidradenitis suppurativa (HS) who applied ruxolitinib cream experienced a greater reduction in the abscess and inflammatory nodule count compared to those who used a vehicle cream, according to a phase 2 trial. HS is a chronic inflammatory skin disease associated with painful inflammatory modules and abscesses. The lack of approved therapies for milder HS makes standard treatments inadequate.
Ruxolitinib, a selective JAK1/JAK2 inhibitor, has shown efficacy in other inflammatory and autoimmune skin diseases
Ruxolitinib Cream Hidradenitis Suppurativa Inflammatory Skin Disease JAK Inhibitor
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ruxolitinib Cream Shows Promise for Hidradenitis SuppurativaTreatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.
Read more »
Unilever Drops Ice Cream, Keeps Face Cream as It Focuses on Power Brands in PortfolioUnilever plans to spin off its ice cream business and slash 7,500 jobs as it seeks cost savings of around 800 million euros over the next three years.
Read more »
Cream Puffs with Strawberry Ice Cream and JamCream puffs with strawberry ice cream and jam are a delicious dessert that can be enjoyed any time of year. The recipe is simple and requires only a few ingredients. The cream puffs are filled with strawberry ice cream, covered in chocolate, and can be served for a romantic evening or as a breakfast treat.
Read more »
Modified CAR-T therapy shows promise in early clinical trialsA modified version of CAR-T therapy, used to treat leukemia and lymphoma, was found to be safe in two small clinical trials. More research is needed to determine its long-term effectiveness.
Read more »
New Blood Test Shows Promise for Early Detection of Colorectal CancerA recent study has found that a cfDNA blood test has shown promising results in detecting colorectal cancer (CRC) early. The test had a sensitivity of 83% for CRC and 13% for advanced precancerous lesions. This noninvasive screening method could provide a more convenient alternative for patients who may decline current screening options.
Read more »
Revolutionary Brain Stimulation Technique Shows Promise for Treating Neurological DisordersScience, Space and Technology News 2024
Read more »